Jidong Jia

19.5k total citations
315 papers, 6.4k citations indexed

About

Jidong Jia is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jidong Jia has authored 315 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Hepatology, 208 papers in Epidemiology and 48 papers in Surgery. Recurrent topics in Jidong Jia's work include Liver Disease Diagnosis and Treatment (174 papers), Hepatitis B Virus Studies (133 papers) and Hepatitis C virus research (115 papers). Jidong Jia is often cited by papers focused on Liver Disease Diagnosis and Treatment (174 papers), Hepatitis B Virus Studies (133 papers) and Hepatitis C virus research (115 papers). Jidong Jia collaborates with scholars based in China, United States and Germany. Jidong Jia's co-authors include Hong You, Yan Cui, Detlef Schuppan, Henry Lik‐Yuen Chan, Eckhart G. Hahn, Jinlin Hou, Xinyan Zhao, Xiaojuan Ou, Teerha Piratvisuth and Yuanyuan Kong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Jidong Jia

299 papers receiving 6.2k citations

Peers

Countries citing papers authored by Jidong Jia

Since Specialization

Citations

This map shows the geographic impact of Jidong Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jidong Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jidong Jia more than expected).

Fields of papers citing papers by Jidong Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jidong Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jidong Jia. The network helps show where Jidong Jia may publish in the future.

Co-authorship network of co-authors of Jidong Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Jidong Jia. A scholar is included among the top collaborators of Jidong Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jidong Jia. Jidong Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (Version 2024) 2025 ·Journal of Clinical and Translational Hepatology ·Suxian Zhao, Jie Li, Lingdi Liu, Sha Huang, Yanhang Gao, Mei Liu, Yu Chen, Lai Wei, Jidong Jia, Hong You, Zhongping Duan, Hui Zhuang, (unknown), Xiaoyuan Xu, Yuemin Nan	0
2	Unstable Recompensation: An Intermediate Subtype in Patients With HBV ‐Related Decompensated Cirrhosis 2025 ·Alimentary Pharmacology & Therapeutics ·(unknown), Zhiying He, (unknown), Zhongjie Hu, Chunqing Zhang, (unknown), Yongfeng Yang, Yan Huang, Wei Rao, Xiaoqian Xu, Xingyu Zhao, (unknown), Yameng Sun, Shuyan Chen, (unknown), Xiaojuan Ou, Xinyan Zhao, Jidong Jia, Bingqiong Wang, (unknown)	2
3	Development and Validation of a Novel Model to Discriminate Idiosyncratic Drug‐Induced Liver Injury and Autoimmune Hepatitis 2025 ·Liver International ·Yu Wang, Xuhui Lin, Ying Sun, Jimin Liu, Jia Li, Qiuju Tian, (unknown), Xiaoli Hu, Liang Wang, (unknown), (unknown), Yan Wang, (unknown), Jidong Jia, Jing Zhang, Zhengsheng Zou, Xinyan Zhao	1
4	Comprehensive approach to controlling chronic hepatitis B in China 2024 ·Clinical and Molecular Hepatology ·Shan Shan, Xinyan Zhao, Jidong Jia	11
5	Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway 2024 ·European Journal of Pharmacology ·(unknown), (unknown), Xiao‐Fan Wang, Chao Xie, Li Li, (unknown), (unknown), Shan Shan, Ping Wang, Tianhui Liu, Fan Xu, (unknown), Jidong Jia	4
6	Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024) 2024 ·Journal of Clinical and Translational Hepatology ·Jian‐Gao Fan, Xiaoyuan Xu, (unknown), Yuemin Nan, Lai Wei, Jidong Jia, Hui Zhuang, Junping Shi, (unknown), C. N. Sun, Jie Li, (unknown), Zhong-Ping Duan	22
7	Intravoxel incoherent motion assessment of liver fibrosis staging in MASLD 2024 ·Abdominal Radiology ·(unknown), Hui Xu, Dawei Yang, (unknown), Xinyan Zhao, (unknown), Yameng Sun, Xiaojuan Ou, Jidong Jia, Hong You, Zhenchang Wang, Zhenghan Yang	3
8	Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021) 2023 ·Journal of Clinical and Translational Hepatology ·Hong You, Weijia Duan, Shuxiang Li, Tingting Lv, Sha Chen, Lungen Lu, Xiong Ma, Ying Han, Yuemin Nan, Xiaoyuan Xu, Zhongping Duan, Lai Wei, Jidong Jia, Hui Zhuang	13
9	[Recompensation of complications in patients with hepatitis B virus-related decompensated cirrhosis treated with entecavir antiviral therapy]. 2023 ·PubMed ·(unknown), Yinan Deng, Hong‐Yo Kang, Huiling Xiang, Yuemin Nan, (unknown), Qinghua Meng, (unknown), Jun Xu, (unknown), Hong Zhao, (unknown), Jidong Jia, Xiaoyuan Xu, Wen Xie	0
10	Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline 2023 ·Annals of Internal Medicine ·Ahmed A. Awan, Marina Berenguer, Annette Bruchfeld, Fabrizio Fabrizi, David S. Goldberg, Jidong Jia, Nassim Kamar, Rosmawati Mohamed, Mário Guimarães Pessôa, Stanislas Pol, Meghan E. Sise, Ethan M. Balk, Craig E. Gordon, Gaelen P. Adam, Michael Cheung, Amy Earley, Paul Martin, Michel Jadoul	5
11	Clinical and laboratory characteristics of hemophagocytic lymphohistiocytosis induced by Leishmania infantum infection 2021 ·SHILAP Revista de lepidopterología ·Qi Shi, Minjun Huang, (unknown), Xiaoyan Zheng, Fei Wang, Yang Zou, Lei Wang, Jidong Jia	2
12	Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study 2020 ·The Journal of Infectious Diseases ·Milan J. Sonneveld, Bettina E. Hansen, Willem Pieter Brouwer, Henry LY Chan, Teerha Piratvisuth, Jidong Jia, Stefan Zeuzem, Rong‐Nan Chien, Robert J. de Knegt, Cynthia Wat, Vedran Pavlovic, Anuj Gaggar, Qing Xie, Marı́a Buti, Robert A. de Man, Harry L.A. Janssen, (unknown)	11
13	A missense variant in complement factor B (CFB) is a potential predictor of 24‐week off‐treatment response to PegIFNα therapy in Chinese HBeAg‐positive chronic hepatitis B patients 2020 ·Alimentary Pharmacology & Therapeutics ·(unknown), Jian Sun, Bin Zhou, (unknown), Qing Xie, Xieer Liang, Rong Fan, Carly Conran, Jianfeng Xu, Yuan Ji, Xinxin Zhang, (unknown), Jidong Jia, Guiqiang Wang, Jinlin Hou, Deke Jiang	14
14	Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis 2020 ·Hepatology ·Wei Chen, Aiting Yang, Jidong Jia, Yury Popov, Detlef Schuppan, Hong You	181
15	Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis 2020 ·Alimentary Pharmacology & Therapeutics ·Milan J. Sonneveld, Willem Pieter Brouwer, Bettina E. Hansen, Henry Lik‐Yuen Chan, Teerha Piratvisuth, Jidong Jia, Stefan Zeuzem, Rong‐Nan Chien, Hannah Choi, Robert J. de Knegt, Cynthia Wat, Vedran Pavlovic, Anuj Gaggar, Qing Xie, Marı́a Buti, Robert A. de Man, Harry L.A. Janssen, (unknown)	20
16	East Asia expert opinion on treatment initiation for chronic hepatitis B 2020 ·Alimentary Pharmacology & Therapeutics ·Jia‐Horng Kao, Tsung‐Hui Hu, Jidong Jia, Masayuki Kurosaki, Young‐Suk Lim, Han‐Chieh Lin, Dong Hyun Sinn, Yasuhito Tanaka, Vincent Wai‐Sun Wong, Man‐Fung Yuen	40
17	Systematic review on the reporting quality of randomized controlled trials in patients with hepatitis B or C in China 2017 ·International Journal of Infectious Diseases ·Na Zeng, (unknown), Zhiying He, Hong Ma, Xiaojuan Ou, Hong You, Yuanyuan Kong, Jidong Jia	6
18	Effect of hepatitis B virus subgenotype on antiviral response in nucleoside‐treated hepatitis B envelope antigen‐positive patients 2017 ·Hepatology Research ·Sheng Shen, Xieer Liang, Kamal Hamed, Yasuhito Tanaka, Katsumi Omagari, Rong Fan, Qing Xie, Deming Tan, Bin Zhou, Jidong Jia, Jinlin Hou, Jian Sun	13
19	No association between IL28B genotype and response to peginterferon alfa-2a (40KD) in HBe antigen-positive and HBe antigen-negative patients with chronic hepatitis B in three large randomized clinical studies 2013 ·Hepatology ·(unknown), Heiner Wedemeyer, Yun‐Fan Liaw, Henry Lik-Yuen Chan, Teerha Piratvisuth, Patrick Marcellin, Jidong Jia, (unknown), (unknown), Maurizia Rossana Brunetto, M. Diago, Selım Gürel, Viacheslav Morozov, Hua He, (unknown), Cynthia Wat, Alexander Thompson	1
20	716 FIVE-YEAR TELBIVUDINE TREATMENT WITH EFFECTIVE VIRAL SUPPRESSION RESULTS IN RESOLUTION OF LIVER INFLAMMATION AND FIBROSIS REGRESSION IN PATIENTS WITH CHRONIC HEPATITIS B 2011 ·Journal of Hepatology ·Jiajie Hou, Dong Xu, (unknown), Zachary Goodman, (unknown), (unknown), (unknown), Qing Xie, Wei Lin, Junqi Niu, (unknown), Hongwei Ren, (unknown), Jidong Jia, W. Bao, Yuliang Dong, Aldo Trylesinski, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact